2007 HCPCS Q0180
Use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen dolasetron mesylate, 100 mg, oral, fda approved prescription anti-emetic, for

  • This is the 2007 version of HCPCS Q0180 - please refer to the 2016 HCPCS code set for the latest version.

  Q0179    Q0181